Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Measures of chemotherapy-induced peripheral neuropathy: a systematic review of psychometric properties.

Griffith KA, Merkies IS, Hill EE, Cornblath DR.

J Peripher Nerv Syst. 2010 Dec;15(4):314-25. doi: 10.1111/j.1529-8027.2010.00292.x. Review.

PMID:
21199103
2.

The total neuropathy score: a tool for measuring chemotherapy-induced peripheral neuropathy.

Smith EM, Beck SL, Cohen J.

Oncol Nurs Forum. 2008 Jan;35(1):96-102. doi: 10.1188/08.ONF.96-102. Review.

PMID:
18192158
3.

Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02.

Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Mukai H, Katsumata N, Sunada Y, Watanabe T, Hausheer FH.

Support Care Cancer. 2009 Dec;17(12):1483-91. doi: 10.1007/s00520-009-0613-7. Epub 2009 Mar 28.

PMID:
19330359
4.

Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy.

Calhoun EA, Welshman EE, Chang CH, Lurain JR, Fishman DA, Hunt TL, Cella D.

Int J Gynecol Cancer. 2003 Nov-Dec;13(6):741-8.

PMID:
14675309
5.

The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale.

Cavaletti G, Frigeni B, Lanzani F, Piatti M, Rota S, Briani C, Zara G, Plasmati R, Pastorelli F, Caraceni A, Pace A, Manicone M, Lissoni A, Colombo N, Bianchi G, Zanna C; Italian NETox Group.

J Peripher Nerv Syst. 2007 Sep;12(3):210-5.

PMID:
17868248
6.
7.

Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool.

Tofthagen CS, McMillan SC, Kip KE.

Cancer Nurs. 2011 Jul-Aug;34(4):E10-20. doi: 10.1097/NCC.0b013e31820251de.

PMID:
21242773
8.

Chemotherapy induced peripheral neuropathy: the modified total neuropathy score in clinical practice.

Vasquez S, Guidon M, McHugh E, Lennon O, Grogan L, Breathnach OS.

Ir J Med Sci. 2014 Mar;183(1):53-8. doi: 10.1007/s11845-013-0971-5. Epub 2013 Jul 7.

PMID:
23832573
9.

Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.

Cavaletti G, Frigeni B, Lanzani F, Mattavelli L, Susani E, Alberti P, Cortinovis D, Bidoli P.

Eur J Cancer. 2010 Feb;46(3):479-94. doi: 10.1016/j.ejca.2009.12.008. Epub 2010 Jan 4. Review.

PMID:
20045310
11.

Chemotherapy-induced peripheral neuropathy: assessment of oncology nurses' knowledge and practice.

Binner M, Ross D, Browner I.

Oncol Nurs Forum. 2011 Jul;38(4):448-54. doi: 10.1188/11.ONF.448-454.

PMID:
21708535
12.

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

Cavaletti G, Cornblath DR, Merkies IS, Postma TJ, Rossi E, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG; CI-PeriNomS Group.

Ann Oncol. 2013 Feb;24(2):454-62. doi: 10.1093/annonc/mds329. Epub 2012 Aug 21.

13.

Chemotherapy-induced peripheral neurotoxicity.

Cavaletti G, Marmiroli P.

Nat Rev Neurol. 2010 Dec;6(12):657-66. doi: 10.1038/nrneurol.2010.160. Epub 2010 Nov 9. Review.

PMID:
21060341
14.

Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.

De Grandis D.

CNS Drugs. 2007;21 Suppl 1:39-43; discussion 45-6. Review.

PMID:
17696592
15.

A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer.

Kuroi K, Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Ohsumi S, Watanabe T, Bain S, Hausheer FH.

Jpn J Clin Oncol. 2008 Nov;38(11):748-54. doi: 10.1093/jjco/hyn100. Epub 2008 Oct 8.

16.

Updating your peripheral neuropathy "know-how".

Marrs J, Newton S.

Clin J Oncol Nurs. 2003 May-Jun;7(3):299-303. Review.

PMID:
12793336
17.

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

Binda D, Vanhoutte EK, Cavaletti G, Cornblath DR, Postma TJ, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG, Merkies IS; CI-PeriNomS study group, Galimberti S, Lanzani F, Mattavelli L, Piatti ML, Bidoli P, Cazzaniga M, Cortinovis D, Lucchetta M, Campagnolo M, Bakkers M, Brouwer B, Boogerd W, Grant R, Reni L, Piras B, Pessino A, Padua L, Granata G, Leandri M, Ghignotti I, Plasmati R, Pastorelli F, Heimans JJ, Eurelings M, Meijer RJ, Grisold W, Lindeck Pozza E, Mazzeo A, Toscano A, Russo M, Tomasello C, Altavilla G, Penas Prado M, Dominguez Gonzalez C, Dorsey SG.

Eur J Cancer. 2013 Sep;49(13):2910-8. doi: 10.1016/j.ejca.2013.04.004. Epub 2013 May 10.

PMID:
23668917
18.

Chemotherapy-induced neuropathy.

Bhagra A, Rao RD.

Curr Oncol Rep. 2007 Jul;9(4):290-9. Review.

PMID:
17588354
19.

Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.

Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F.

Semin Oncol. 2006 Feb;33(1):15-49. Review.

PMID:
16473643
20.

[Chemotherapy-induced peripheral neuropathy: an unresolved issue].

Velasco R, Bruna J.

Neurologia. 2010 Mar;25(2):116-31. Review. Spanish.

Items per page

Supplemental Content

Write to the Help Desk